Literature DB >> 31773997

Peripheral T-cell lymphomas as fingolimod-associated lymphoproliferative disorder for patients with multiple sclerosis - case report with literature review.

Hidetsugu Kawai1, Hiromichi Matsushita2,3, Hibiki Akashi1, Daisuke Furuya1, Shohei Kawakami1, Rikio Suzuki1, Makiko Moriuchi4, Yoshiaki Ogawa1, Hiroshi Kawada1, Naoya Nakamura5, Kiyoshi Ando1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31773997     DOI： 10.1080/10428194.2019.1691197

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  3 in total

1.  Primary central nervous system lymphoma in a patient with multiple sclerosis using fingolimod.

Authors:  Matheus Bernardon Morillos; Paulo Henrique Pires de Aguiar; Paulo Roberto Franceschini; Juliana Ávila Duarte; Cristian Daniel Piccini; Alessandro Finkelsztejn
Journal:  Neurol Sci       Date:  2022-08-29       Impact factor: 3.830

Review 2.  Sphingolipids and Lymphomas: A Double-Edged Sword.

Authors:  Alfredo Pherez-Farah; Rosa Del Carmen López-Sánchez; Luis Mario Villela-Martínez; Rocío Ortiz-López; Brady E Beltrán; José Ascención Hernández-Hernández
Journal:  Cancers (Basel)       Date:  2022-04-19       Impact factor: 6.575

Review 3.  Safety of Newer Disease Modifying Therapies in Multiple Sclerosis.

Authors:  Georges Jalkh; Rachelle Abi Nahed; Gabrielle Macaron; Mary Rensel
Journal:  Vaccines (Basel)       Date:  2020-12-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.